Cambridge, MA, United States of America

William Stuart Somers


Average Co-Inventor Count = 5.9

ph-index = 6

Forward Citations = 94(Granted Patents)


Location History:

  • Boston, MA (US) (2002)
  • Cambridge, MA (US) (2002 - 2009)
  • Lexington, MA (US) (2009 - 2021)

Company Filing History:


Years Active: 2002-2021

Loading Chart...
13 patents (USPTO):

Title: Innovations of William Stuart Somers

Introduction

William Stuart Somers is a notable inventor based in Cambridge, MA (US). He holds a total of 13 patents, showcasing his significant contributions to the field of biotechnology. His work primarily focuses on developing innovative solutions for medical treatments.

Latest Patents

One of Somers' latest patents is the invention of dual PDGF/VEGF antagonists. This invention provides a dual VEGF/PDGF antagonist that comprises a VEGF antagonist linked to a PDGF antagonist. The VEGF antagonist can be an antibody to a VEGF or VEGFR or a VEGFR extracellular trap segment. This segment inhibits the binding of at least one VEGFR to at least one VEGF. The PDGF antagonist is similarly an antibody to a PDGF or PDGFR or a PDGFR extracellular trap segment, which inhibits the binding of at least one PDGFR and at least one PDGF. The dual antagonist is preferably conjugated to a half-life extending moiety, such as a HEMA-PC polymer. This dual antagonist is particularly useful for treating wet age-related macular degeneration.

Career Highlights

Throughout his career, Somers has worked with prominent companies in the biotechnology sector, including Wyeth and Genetics Institute, Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in developing medical treatments.

Collaborations

Some of his notable coworkers include Mark L. Stahl and Lidia Mosyak. Their collaboration has likely played a role in advancing the research and development of his inventions.

Conclusion

William Stuart Somers is a distinguished inventor whose work in developing dual PDGF/VEGF antagonists has the potential to significantly impact the treatment of wet age-related macular degeneration. His contributions to biotechnology continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…